Publication | Closed Access

Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study

UrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorCancer TreatmentImmunotherapyOncologyRadiation Oncology